Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Review publication

Data source

Referenceopen allclose all

Reference Type:
review article or handbook
Title:
Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and TEA-lactates, methyl, ethyl, isopropyl, …
Author:
Andersen, F.A.
Year:
1998
Bibliographic source:
International Journal of Toxicology 17 (Suppl. 1)
Reference Type:
other: FDA review
Title:
FDA summary action review of the new drug application submitted by Bristol-Myers on Lac-Hydrin (Ammonium lactate) 12% lotion
Author:
FDA
Year:
1988
Bibliographic source:
Washington, DC: FDA

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
See "Details on study design"
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Reference substance 001
Cas Number:
52003-58-4
Test material form:
solid: crystalline
Specific details on test material used for the study:
A 12% Ammonium lactate lotion was used in the modified Draize prophetic patch tests.

Method

Type of population:
not specified
Ethical approval:
not specified
Route of administration:
dermal
Details on study design:
Two modified Draize prophetic patch tests were conducted, each using 203 subjects, to investigate the contact sensitization potential of a 12% Ammonium Lactate lotion. In both studies, the lotion was applied to the back under occlusive patches three times per week, for a 48-h period during the week and a 72-h period over the weekends, for a total of 10 applications. After a 2-week non-treatment period, a challenge patch was applied to an untreated site for 72 h.

Results and discussion

Results of examinations:
No sensitisation was reported in either study.

Applicant's summary and conclusion

Conclusions:
In conclusion, no sensitisation was reported in two modified Draize prophetic patch tests.
Executive summary:

Two modified Draize prophetic patch tests were conducted, each using 203 subjects, to investigate the contact sensitization potential of a 12% Ammonium Lactate lotion. In both studies, the lotion was applied to the back under occlusive patches three times per week, for a 48-h period during the week and a 72-h period over the weekends, for a total of 10 applications. After a 2-week non-treatment period, a challenge patch was applied to an untreated site for 72 h. No semsitisation was reported in either study.